Bacaro, Alejandro D.
HRN: 24-48-47 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/06/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
02/06/2024
02/12/2024
IV
1.5g
Q6h
CAP MR
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes